Navigation Links
Pharma and Biotech Leaders to Converge in Shanghai

SHANGHAI, Nov. 9 /PRNewswire-Asia/ -- The pharma and biotech sectors are at a pivotal point in their evolution. The companies are facing significant pressure to change with thinning pipelines, skyrocketing R&D costs, calls for lower prices and a greater regulatory burden, these conditions together with the financial crisis have made the work of creating new drugs harder than ever. Big pharmaceutical companies are being forced to globalize their R&D operations, especially to emerging markets.

Under this background, leaders of pharma and biotech companies from around the world will gather in Shanghai on March 4-5, 2010 at Asia Pharma R&D Leaders 2010 for strategies to capitalize on the enormous opportunity the booming Asia Market provides.

This event focuses on the operational, regulatory, and strategic challenges of outsourcing your drug discovery work to Asia.

Hear from distinguished industry experts at Asia Pharma R&D Leaders 2010. Some of this year's highlighted topics include:

    -- Partnering for innovation in Asia, new collaboration opportunities with
       big pharma

       -- Laurent Bertin, Vice President, R&D External Innovation, Sanofi-
       -- Hans-Jochiam Bohm, Head of Global Chemistry, Hoffman La-Roche
       -- Daniel Grant, Head of Strategic Alliances, Pfizer Australia
       -- Pierre Desmons, Director, Head of Development Partnerships,
          GlaxoSmithKline Biologicals

    -- Regulatory updates in China and how FDA is making sure the quality of
       outsourced work

       -- Christopher Hickey, Country Director (China), U.S. Food and Drug

    -- Successful stories of R&D operation management in Asia and Do's &
       Don'ts in outsourcing

       -- Steve Yang, Head of Research Asia Global R&D, Pfizer
       -- Lily Lee, Senior Vice President and Head of Pharmaceutical R&D Asia,
          Johnson and Johnson
       -- Li Chen, Chief Scientific Officer Roche R&D China
       -- Tony Zhang, Managing Director and Site Head of China, Eli Lilly
          Global R&D
       -- Samantha Du, CEO, Hutchison MediPharma
       -- Richard Wang, Director, Strategic Alliance and Collaboration for
          Asia, AstraZeneca
       -- Yoshiki Nishikawa, Director of Kobe Pharma Research Institute Nippon,
          Boehringer Ingelheim

Plus, the event sets up an effective platform for you to meet face to face with a variety of Asia's local CROs and leading clinical practitioners to discuss the specifics of your outsourcing requirements.

An international audience consisting of senior-level pharma and biotech executives from the R&D, clinical development, business development, global market access, licensing, and regulatory affairs functions will be in attendance. For the full program and list of companies scheduled to attend, please visit the event website at .

For more information on registration and sponsoring/exhibiting, please contact:

Daniel Chen

Tel: +86-21-3251-6110


SOURCE Global Leaders Institute

SOURCE Global Leaders Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th
2. Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference
3. DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix
4. Onyx Pharmaceuticals to Present at the Credit Suisse 18th Annual Healthcare Conference
5. Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results
6. ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update
8. OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
9. Laureate Pharma Welcomes Three New Members to Business Development Team
10. Pharmasset to Webcast an Investor Event from the AASLD Meeting
11. ViroPharma to Present at Three November Healthcare Conferences
Post Your Comments:
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... environment are paramount. Insertion points for in-line sensors can represent a weak spot ... InTrac 781/784 series of retractable sensor housings , which are designed to ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Inc., on being named to Deloitte's 2015 Technology Fast 500 list of the ... manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic tooth ...
(Date:11/24/2015)... 24, 2015 Capricor Therapeutics, Inc. ... the discovery, development and commercialization of first-in-class therapeutics, today ... Officer, is scheduled to present at the 2015 Piper ... a.m. EST, at The Lotte New York Palace Hotel ... . --> . ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
Breaking Biology News(10 mins):